| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997741A Novel mite allergen |
| 07/11/2007 | CN1997657A Therapeutic heparins and their binding to interleukins 4 and 5, and PECAM-1 |
| 07/11/2007 | CN1997645A Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
| 07/11/2007 | CN1997395A Drug having regulatory cell ligand contained in liposome |
| 07/11/2007 | CN1997369A Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 07/11/2007 | CN1997367A Composition for the prevention and treatment of allergic inflammatory disease |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1995019A Kukoline salt compounds and its preparation method |
| 07/11/2007 | CN1994357A Composition of blueberry and propolis for improving immunity |
| 07/11/2007 | CN1994338A Novel use of Sarcandra glabra aqueous extract |
| 07/11/2007 | CN1994319A Deer blood powder capsule and preparation process thereof |
| 07/11/2007 | CN1994304A Compound orally disintegrating tablet containing loratadine and ambroxol and preparation process thereof |
| 07/11/2007 | CN1994298A Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof |
| 07/11/2007 | CN1994295A Enteric-coated pharmaceutical composition of mycophenolic acid salt |
| 07/11/2007 | CN1994129A A sea cucumber nutrient and preparation method thereof |
| 07/11/2007 | CN1994119A Fig active element and preparation process thereof |
| 07/11/2007 | CN1325650C Delivery system for porcine somatotropin |
| 07/11/2007 | CN1325498C Novel crystalline compound |
| 07/11/2007 | CN1325497C Pharmaceutically active isoindoline derivs. |
| 07/11/2007 | CN1325491C Novel crystals |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |
| 07/11/2007 | CN1325479C Pyrimidine compounds |
| 07/11/2007 | CN1325117C 联合疫苗组合物 Combined vaccine composition |
| 07/11/2007 | CN1325115C Methods for CTL and T helper cell in therapeutic vaccination |
| 07/11/2007 | CN1325077C Animal immunopotentiator using astragalus as basic remedy |
| 07/11/2007 | CN1325060C Medicated cream and its prepn process |
| 07/11/2007 | CN1325052C Benzothiazole derivatives |
| 07/10/2007 | US7241900 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 07/10/2007 | US7241890 Heat shock protein 90 inhibitors; breast cancer, melanomas; inflammation, infectious diseases, autoimmune disorders, ischemia |
| 07/10/2007 | US7241877 Humanised antibodies |
| 07/10/2007 | US7241873 Recombinant anti-osteopontin antibody and use thereof |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241747 For therapy and prophylaxis of diseases where bone formation is desired, such as osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus; also exhibit pronounced activity in arresting the proliferation of undifferentiated cells |
| 07/10/2007 | US7241745 Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives |
| 07/10/2007 | US7241742 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241618 A polynucleotide comprising a RNA polymerase promoter, able encoding a siRNA; treating cancer and genetic disorders; genetic engineering, inhibit gene expression of a target gene |
| 07/10/2007 | US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to |
| 07/10/2007 | US7241450 DNA sequence and recombinant production of a Gramineae allergen |
| 07/10/2007 | US7241448 T helper cell epitopes |
| 07/10/2007 | CA2421910C Xanthine phosphodiesterase v inhibitors |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2199401C Pyrimido[5,4-d]pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 07/10/2007 | CA2124769C Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/05/2007 | WO2007076247A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 07/05/2007 | WO2007075605A2 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production |
| 07/05/2007 | WO2007075468A1 Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof |
| 07/05/2007 | WO2007074788A1 Anti-tumor agent and immunostimulating agent |
| 07/05/2007 | WO2007074198A1 Selective peptides that inhibit the biological activity of calcineurin |
| 07/05/2007 | WO2007074135A2 Infant immunological formula |
| 07/05/2007 | WO2007073785A1 Therapeutic use of an extract from the leaves of nerium oleander |
| 07/05/2007 | WO2007073703A1 Cytoprotective pharmaceutical combination which can be used in the prevention and treatment of systemic inflammatory response syndrome |
| 07/05/2007 | WO2007042554A3 Methods and compositions for treating immune disorders |
| 07/05/2007 | WO2007036028A9 Compositions for and methods of granzyme b inhibition |
| 07/05/2007 | WO2006056779A3 ANTI-TNF ALPHA ANTIBODIES WHICH SELECTIVELY INHIBIT TNF ALPHA SIGNALLING THROUGH THE p55R |
| 07/05/2007 | WO2004069183A3 Immune regulation based on the targeting of early activation molecules |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155817 Indolylmaleimide derivatives |
| 07/05/2007 | US20070155812 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents |
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid |
| 07/05/2007 | US20070155804 Mitotic kinesin inhibitor |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
| 07/05/2007 | US20070155703 Pharmaceutically active compounds and methods of use thereof |
| 07/05/2007 | US20070155678 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 07/05/2007 | US20070155663 Use of chemokine receptor agonists for stem cell transplantation |
| 07/05/2007 | US20070155002 Amino acid sequence from active principles in musk and their acetic salts, preparation and use thereof |
| 07/05/2007 | US20070154995 Development of human monoclonal antibodies and uses thereof |
| 07/05/2007 | US20070154991 Transgenic bacillus for use as bioreactor in production of capsular polysaccharide A |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154541 Seamless capsule containing water-soluble active substance |
| 07/05/2007 | US20070154477 Humanized anti-CD3 specific antibodies |
| 07/05/2007 | DE102005054700A1 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases |
| 07/05/2007 | CA2836123A1 Compositions and methods for producing a composition |
| 07/05/2007 | CA2635770A1 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 07/05/2007 | CA2635342A1 Cytoprotective pharmaceutical combination which can be used in the prevention and treatment of systemic inflammatory response syndrome |
| 07/05/2007 | CA2634198A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/05/2007 | CA2634061A1 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders |
| 07/05/2007 | CA2634017A1 Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods |
| 07/05/2007 | CA2633992A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 07/05/2007 | CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | CA2632262A1 Method of using .beta.-hydroxy-.beta.-methylbutyrate |
| 07/04/2007 | EP1803811A1 Chimeric (double) decoy |
| 07/04/2007 | EP1803810A1 Integrin antagonists |
| 07/04/2007 | EP1803808A1 Lecithinized superoxide dismutase composition and process for producing the same |
| 07/04/2007 | EP1803807A2 Virulence genes, proteins, and their use |
| 07/04/2007 | EP1803733A2 Method for treating inflammation |